Literature DB >> 21516478

Measures of relative importance for health-related quality of life.

Tolulope T Sajobi1, Lisa M Lix, Ian Clara, John Walker, Lesley A Graff, Patricia Rawsthorne, Norine Miller, Linda Rogala, Rachel Carr, Charles N Bernstein.   

Abstract

PURPOSE: In health-related quality of life (HRQOL) studies, data are often collected on multiple domains for two or more groups of study participants. Quantitative measures of relative importance, which are used to rank order the domains based on their ability to discriminate between groups, are an alternative to multiple tests of significance on the group differences. This study describes relative importance measures based on logistic regression (LR) and multivariate analysis of variance (MANOVA) models.
METHODS: Relative importance measures are illustrated using data from the Manitoba Inflammatory Bowel Disease (IBD) Cohort Study. Study participants with self-reported active (n = 244) and inactive (n = 105) disease were compared on 12 HRQOL domains from the Inflammatory Bowel Disease Questionnaire (IBDQ) and Medical Outcomes Study 36-item Short-Form (SF-36) Questionnaire.
RESULTS: All but two relative importance measures ranked the IBDQ bowel symptoms and emotional health domains as most important.
CONCLUSIONS: MANOVA-based importance measures are recommended for multivariate normal data and when group covariances are equal, while LR measures are recommended for non-normal data and when the correlations among the domains are small. Relative importance measures can be used in exploratory studies to identify a small set of domains for further research.

Entities:  

Mesh:

Year:  2011        PMID: 21516478     DOI: 10.1007/s11136-011-9914-7

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  22 in total

Review 1.  Policy capturing as an approach to understanding and improving performance appraisal: a review of the literature.

Authors:  C J Hobson; F W Gibson
Journal:  Acad Manage Rev       Date:  1983-10

2.  Interpreting Discriminant Functions: A Data Analytic Approach.

Authors:  D R Thomas
Journal:  Multivariate Behav Res       Date:  1992-07-01       Impact factor: 5.923

3.  Quality of life of nasopharyngeal carcinoma survivors in Mainland China.

Authors:  Yong Wu; Wei-Han Hu; Yun-Fei Xia; Jun Ma; Meng-Zhong Liu; Nian-Ji Cui
Journal:  Qual Life Res       Date:  2006-10-11       Impact factor: 4.147

4.  Application of robust statistical methods for sensitivity analysis of health-related quality of life outcomes.

Authors:  Jennifer L Beaumont; Lisa M Lix; Kathleen J Yost; Elizabeth A Hahn
Journal:  Qual Life Res       Date:  2006-04       Impact factor: 4.147

5.  A general distribution theory for a class of likelihood criteria.

Authors:  G E P BOX
Journal:  Biometrika       Date:  1949-12       Impact factor: 2.445

6.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

7.  Relative importance of personality and general mental ability in managers' judgments of applicant qualifications.

Authors:  W S Dunn; M K Mount; M R Barrick; D S Ones
Journal:  J Appl Psychol       Date:  1995-08

Review 8.  Incomplete quality of life data in randomized trials: missing forms.

Authors:  D Curran; G Molenberghs; P M Fayers; D Machin
Journal:  Stat Med       Date:  1998 Mar 15-Apr 15       Impact factor: 2.373

Review 9.  Methods to explain the clinical significance of health status measures.

Authors:  Gordon H Guyatt; David Osoba; Albert W Wu; Kathleen W Wyrwich; Geoffrey R Norman
Journal:  Mayo Clin Proc       Date:  2002-04       Impact factor: 7.616

10.  Health related quality of life in 10-year-old schoolchildren.

Authors:  Camilla Laaksonen; Minna Aromaa; Olli J Heinonen; Leena Koivusilta; Pasi Koski; Sakari Suominen; Tero Vahlberg; Sanna Salanterä
Journal:  Qual Life Res       Date:  2008-09-12       Impact factor: 4.147

View more
  6 in total

1.  IBD: Trying to optimize a tool to measure disability in IBD.

Authors:  Charles N Bernstein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-08-09       Impact factor: 46.802

2.  Method variation in the impact of missing data on response shift detection.

Authors:  Carolyn E Schwartz; Tolulope T Sajobi; Mathilde G E Verdam; Veronique Sebille; Lisa M Lix; Alice Guilleux; Mirjam A G Sprangers
Journal:  Qual Life Res       Date:  2014-07-10       Impact factor: 4.147

3.  Identifying reprioritization response shift in a stroke caregiver population: a comparison of missing data methods.

Authors:  Tolulope T Sajobi; Lisa M Lix; Gurbakhshash Singh; Mark Lowerison; Jordan Engbers; Nancy E Mayo
Journal:  Qual Life Res       Date:  2014-10-26       Impact factor: 4.147

4.  Relative importance measures for reprioritization response shift.

Authors:  Lisa M Lix; Tolulope T Sajobi; Richard Sawatzky; Juxin Liu; Nancy E Mayo; Yuhui Huang; Lesley A Graff; John R Walker; Jason Ediger; Ian Clara; Kathryn Sexton; Rachel Carr; Charles N Bernstein
Journal:  Qual Life Res       Date:  2012-06-15       Impact factor: 4.147

5.  Changing values, changing outcomes: the influence of reprioritization response shift on outcome assessment after spine surgery.

Authors:  Carolyn E Schwartz; Tolulope T Sajobi; Lisa M Lix; Brian R Quaranto; Joel A Finkelstein
Journal:  Qual Life Res       Date:  2013-03-22       Impact factor: 4.147

6.  The Manitoba Personalized Lifestyle Research (TMPLR) study protocol: a multicentre bidirectional observational cohort study with administrative health record linkage investigating the interactions between lifestyle and health in Manitoba, Canada.

Authors:  Dylan Mackay; Rebecca C Mollard; Matthew Granger; Sharon Bruce; Heather Blewett; Jared Carlberg; Todd Duhamel; Peter Eck; Patrick Faucher; Naomi C Hamm; Ehsan Khafipour; Lisa Lix; Diana McMillan; Semone Myrie; Amir Ravandi; Navdeep Tangri; Meghan Azad; Peter Jh Jones
Journal:  BMJ Open       Date:  2019-10-10       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.